Gero
Type
investor
Founded
2018
Funding Rounds
1
Portfolio companies
1
About Gero
Gero is an AI-driven biotechnology company that builds physics-guided machine learning platforms and large health models to identify therapeutic targets and design interventions for aging and age-related diseases. The company applies interpretable generative models trained on longitudinal human health data to accelerate target discovery and preclinical drug development, and partners with pharmaceutical organizations to translate platform discoveries into therapeutics.
Gero investments captured (1)
| Company Name | Stage | Total Deal Amount | Date |
|---|---|---|---|
| Pre-Series A | $1.5m | Dec 21, 2022 |